STERIS plc (STE)
USD 207.01
(-1.19%)
USD 207.01
(-1.19%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.41 Billion USD | 5.09% |
| 2023 | 1.34 Billion USD | 193.69% |
| 2022 | 957.2 Million USD | -21.53% |
| 2021 | 800.32 Million USD | 0.78% |
| 2020 | 743.17 Million USD | 13.7% |
| 2019 | 693.08 Million USD | 17.29% |
| 2018 | 594.52 Million USD | 17.09% |
| 2017 | 503 Million USD | 63.16% |
| 2016 | 438.73 Million USD | -6.69% |
| 2015 | 319.54 Million USD | -2.91% |
| 2014 | 303.8 Million USD | 12.05% |
| 2013 | 294.51 Million USD | -11.36% |
| 2012 | 286.07 Million USD | 137.16% |
| 2011 | 140.35 Million USD | -53.61% |
| 2010 | 261.2 Million USD | -10.85% |
| 2009 | 235.82 Million USD | 10.19% |
| 2008 | 188.55 Million USD | 2.9% |
| 2007 | 200.39 Million USD | -3.26% |
| 2006 | 170.97 Million USD | 11.24% |
| 2005 | 196.18 Million USD | 3.78% |
| 2004 | 189.03 Million USD | 9.73% |
| 2003 | 172.28 Million USD | 35.13% |
| 2002 | 127.49 Million USD | 8.68% |
| 2001 | 117.31 Million USD | 69.1% |
| 2000 | 69.37 Million USD | -58.73% |
| 1999 | 169.7 Million USD | 22.87% |
| 1998 | 136.81 Million USD | -26.91% |
| 1997 | 100.9 Million USD | 778.87% |
| 1996 | 89.5 Million USD | 55.47% |
| 1995 | 84.3 Million USD | 69.14% |
| 1994 | 8.7 Million USD | 237.5% |
| 1993 | 2.7 Million USD | 1100.0% |
| 1992 | 200 Thousand USD | -50.0% |
| 1991 | 400 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 185.85 Million USD | 4.78% |
| 2024 FY | - USD | 17.63% |
| 2024 Q3 | 358.87 Million USD | 2.38% |
| 2024 Q4 | 333.82 Million USD | -7.91% |
| 2024 Q1 | 188.92 Million USD | -8.07% |
| 2023 FY | - USD | 193.69% |
| 2023 Q2 | 318.09 Million USD | 100.76% |
| 2023 Q1 | 158.44 Million USD | 72.37% |
| 2023 Q3 | 190.88 Million USD | -39.99% |
| 2023 Q4 | 226.11 Million USD | 18.46% |
| 2022 Q1 | 76.47 Million USD | -44.67% |
| 2022 FY | - USD | -21.53% |
| 2022 Q2 | 116.92 Million USD | 52.9% |
| 2022 Q3 | 202.51 Million USD | 73.21% |
| 2022 Q4 | 91.92 Million USD | -54.61% |
| 2021 FY | - USD | 0.78% |
| 2021 Q4 | 138.21 Million USD | -6.02% |
| 2021 Q1 | 114.33 Million USD | -27.54% |
| 2021 Q3 | 147.07 Million USD | 4.22% |
| 2021 Q2 | 141.11 Million USD | 23.42% |
| 2020 FY | - USD | 13.7% |
| 2020 Q2 | 126.18 Million USD | 11.8% |
| 2020 Q3 | 192.87 Million USD | 52.85% |
| 2020 Q4 | 157.77 Million USD | -18.2% |
| 2020 Q1 | 112.86 Million USD | -25.03% |
| 2019 Q4 | 150.55 Million USD | -15.62% |
| 2019 Q3 | 178.41 Million USD | 16.79% |
| 2019 Q2 | 152.76 Million USD | 7.85% |
| 2019 FY | - USD | 17.29% |
| 2019 Q1 | 141.64 Million USD | 24.78% |
| 2018 Q4 | 113.51 Million USD | 8.81% |
| 2018 FY | - USD | 17.09% |
| 2018 Q3 | 104.32 Million USD | 4.9% |
| 2018 Q2 | 99.45 Million USD | -23.74% |
| 2018 Q1 | 130.42 Million USD | 122.5% |
| 2017 Q3 | 142.63 Million USD | 104.76% |
| 2017 FY | - USD | 63.16% |
| 2017 Q1 | 127.95 Million USD | 28.42% |
| 2017 Q2 | 69.65 Million USD | -45.56% |
| 2017 Q4 | 58.61 Million USD | -58.9% |
| 2016 Q1 | 42.76 Million USD | -36.66% |
| 2016 Q2 | 47.01 Million USD | 9.94% |
| 2016 Q3 | 91.76 Million USD | 95.17% |
| 2016 Q4 | 99.63 Million USD | 8.58% |
| 2016 FY | - USD | -6.69% |
| 2015 FY | - USD | -2.91% |
| 2015 Q2 | 82.16 Million USD | 87.48% |
| 2015 Q1 | 43.82 Million USD | -47.99% |
| 2015 Q3 | 59.12 Million USD | -28.03% |
| 2015 Q4 | 67.51 Million USD | 14.18% |
| 2014 Q3 | 57.5 Million USD | 14.24% |
| 2014 Q4 | 84.25 Million USD | 46.52% |
| 2014 FY | - USD | 12.05% |
| 2014 Q1 | 41.11 Million USD | -34.9% |
| 2014 Q2 | 50.33 Million USD | 22.42% |
| 2013 Q3 | 34.76 Million USD | -44.09% |
| 2013 Q4 | 63.15 Million USD | 81.65% |
| 2013 FY | - USD | -11.36% |
| 2013 Q1 | 62.76 Million USD | -30.03% |
| 2013 Q2 | 62.18 Million USD | -0.93% |
| 2012 Q4 | 89.69 Million USD | 52.85% |
| 2012 Q1 | 50.52 Million USD | -18.57% |
| 2012 Q3 | 58.68 Million USD | 16.81% |
| 2012 FY | - USD | 137.16% |
| 2012 Q2 | 50.24 Million USD | -0.56% |
| 2011 Q4 | 62.04 Million USD | -20.56% |
| 2011 Q1 | -62.31 Million USD | -187.83% |
| 2011 Q2 | 57.92 Million USD | 192.95% |
| 2011 Q3 | 78.1 Million USD | 34.84% |
| 2011 FY | - USD | -53.61% |
| 2010 Q3 | 59.45 Million USD | -7.36% |
| 2010 FY | - USD | -10.85% |
| 2010 Q2 | 64.17 Million USD | 51.22% |
| 2010 Q4 | 70.95 Million USD | 19.34% |
| 2010 Q1 | 42.44 Million USD | -31.79% |
| 2009 FY | - USD | 10.19% |
| 2009 Q1 | 49.9 Million USD | -39.28% |
| 2009 Q4 | 62.22 Million USD | -5.48% |
| 2009 Q3 | 65.82 Million USD | 7.18% |
| 2009 Q2 | 61.41 Million USD | 23.06% |
| 2008 Q4 | 82.18 Million USD | 59.96% |
| 2008 FY | - USD | 2.9% |
| 2008 Q2 | 43.74 Million USD | 9.55% |
| 2008 Q1 | 39.93 Million USD | -43.05% |
| 2008 Q3 | 51.38 Million USD | 17.45% |
| 2007 Q2 | 109.33 Million USD | 156.93% |
| 2007 Q3 | 54.8 Million USD | -49.88% |
| 2007 Q4 | 70.11 Million USD | 27.95% |
| 2007 FY | - USD | -3.26% |
| 2007 Q1 | 42.55 Million USD | -28.74% |
| 2006 Q4 | 59.72 Million USD | 13.25% |
| 2006 Q2 | 42.52 Million USD | 5.16% |
| 2006 Q1 | 40.43 Million USD | -32.49% |
| 2006 Q3 | 52.73 Million USD | 24.01% |
| 2006 FY | - USD | 11.24% |
| 2005 Q2 | 143.48 Million USD | 262.33% |
| 2005 Q3 | 53.08 Million USD | -63.01% |
| 2005 FY | - USD | 3.78% |
| 2005 Q4 | 59.89 Million USD | 12.84% |
| 2005 Q1 | 39.6 Million USD | -29.51% |
| 2004 Q1 | 37.9 Million USD | -29.7% |
| 2004 Q3 | 50.4 Million USD | 13.16% |
| 2004 Q2 | 44.54 Million USD | 17.51% |
| 2004 Q4 | 56.17 Million USD | 11.44% |
| 2004 FY | - USD | 9.73% |
| 2003 Q2 | 41.49 Million USD | 30.32% |
| 2003 Q3 | 45.01 Million USD | 8.48% |
| 2003 FY | - USD | 35.13% |
| 2003 Q1 | 31.84 Million USD | -23.78% |
| 2003 Q4 | 53.92 Million USD | 19.79% |
| 2002 Q3 | 35.13 Million USD | 22.93% |
| 2002 Q1 | 22 Million USD | -45.66% |
| 2002 FY | - USD | 8.68% |
| 2002 Q4 | 41.77 Million USD | 18.91% |
| 2002 Q2 | 28.58 Million USD | 29.9% |
| 2001 Q2 | 27.12 Million USD | 63.23% |
| 2001 FY | - USD | 69.1% |
| 2001 Q4 | 40.49 Million USD | 22.43% |
| 2001 Q1 | 16.61 Million USD | 165.37% |
| 2001 Q3 | 33.07 Million USD | 21.94% |
| 2000 Q4 | -25.42 Million USD | -183.9% |
| 2000 FY | - USD | -58.73% |
| 2000 Q3 | 30.3 Million USD | -16.76% |
| 2000 Q2 | 36.4 Million USD | 31.88% |
| 2000 Q1 | 28.01 Million USD | -41.03% |
| 1999 Q4 | 47.7 Million USD | -2.5% |
| 1999 FY | - USD | 22.87% |
| 1999 Q1 | 32.89 Million USD | -23.4% |
| 1999 Q2 | 40.8 Million USD | 22.8% |
| 1999 Q3 | 48.2 Million USD | 18.81% |
| 1998 Q3 | 38.36 Million USD | 23.05% |
| 1998 FY | - USD | -26.91% |
| 1998 Q1 | 24.32 Million USD | -19.97% |
| 1998 Q2 | 31.17 Million USD | 28.15% |
| 1998 Q4 | 42.95 Million USD | 11.96% |
| 1997 Q3 | 25.6 Million USD | 11.16% |
| 1997 Q1 | 20.6 Million USD | 1559.09% |
| 1997 FY | - USD | 778.87% |
| 1997 Q4 | 31.4 Million USD | 22.09% |
| 1997 Q2 | 23.3 Million USD | -79.54% |
| 1996 Q2 | 5 Million USD | 20.0% |
| 1996 FY | - USD | 55.47% |
| 1996 Q4 | 6.8 Million USD | 11.86% |
| 1996 Q3 | 6.1 Million USD | 22.92% |
| 1996 Q1 | 4.2 Million USD | -6.98% |
| 1995 Q2 | 3.3 Million USD | 19.23% |
| 1995 Q3 | 3.8 Million USD | 19.35% |
| 1995 Q4 | 4.4 Million USD | 16.22% |
| 1995 FY | - USD | 69.14% |
| 1995 Q1 | 2.8 Million USD | -7.14% |
| 1994 Q2 | 1.9 Million USD | 20.0% |
| 1994 Q4 | 3 Million USD | 21.74% |
| 1994 Q3 | 2.3 Million USD | 27.78% |
| 1994 Q1 | 1.6 Million USD | 25.0% |
| 1994 FY | - USD | 237.5% |
| 1993 Q1 | 300 Thousand USD | 103.66% |
| 1993 FY | - USD | 1100.0% |
| 1993 Q2 | 400 Thousand USD | 0.0% |
| 1993 Q3 | 800 Thousand USD | 133.33% |
| 1993 Q4 | 1.3 Million USD | 71.43% |
| 1992 Q2 | 2.5 Million USD | 8.7% |
| 1992 Q4 | -8.2 Million USD | -341.18% |
| 1992 FY | - USD | -50.0% |
| 1992 Q1 | 2.3 Million USD | 135.94% |
| 1992 Q3 | 3.4 Million USD | 36.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q3 | 2.5 Million USD | 4.17% |
| 1991 Q1 | 1.6 Million USD | 0.0% |
| 1991 Q2 | 2.4 Million USD | 50.0% |
| 1991 Q4 | -6.4 Million USD | -356.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Abbott Laboratories | 10.46 Billion USD | 86.501% |
| Allurion Technologies Inc. | -69.03 Million USD | 2146.045% |
| Artivion, Inc. | 38.14 Million USD | -3603.018% |
| Avanos Medical, Inc. | 53.2 Million USD | -2554.897% |
| Butterfly Network, Inc. | -124.84 Million USD | 1231.336% |
| Butterfly Network, Inc. | -124.84 Million USD | 1231.336% |
| Bio-Rad Laboratories, Inc. | -608.26 Million USD | 332.202% |
| Boston Scientific Corporation | 3.45 Billion USD | 59.096% |
| Perspective Therapeutics, Inc. | -14.83 Million USD | 9618.837% |
| CONMED Corporation | 182.18 Million USD | -675.254% |
| Edwards Lifesciences Corporation | 1.76 Billion USD | 20.095% |
| Paragon 28, Inc. | -36.61 Million USD | 3957.554% |
| Glaukos Corporation | -82.11 Million USD | 1820.012% |
| Globus Medical, Inc. | 418.23 Million USD | -237.703% |
| Inspire Medical Systems, Inc. | -17.06 Million USD | 8379.045% |
| Integer Holdings Corporation | 282.05 Million USD | -400.748% |
| Medtronic plc | 9.05 Billion USD | 84.404% |
| Nevro Corp. | -78.31 Million USD | 1903.607% |
| Owlet, Inc. | -27.48 Million USD | 5238.073% |
| Penumbra, Inc. | 111.99 Million USD | -1161.121% |
| Vicarious Surgical Inc. | -69.19 Million USD | 2141.284% |
| Smith & Nephew plc | 979 Million USD | -44.27% |
| Sonendo, Inc. | -54.76 Million USD | 2678.887% |
| Stryker Corporation | 5.16 Billion USD | 72.628% |
| Vapotherm, Inc. | -34.35 Million USD | 4210.967% |
| Zimmer Biomet Holdings, Inc. | 2.44 Billion USD | 42.325% |